Biotech Values

[ThomasS]

Teva Pharm: Copaxone significantly reduced brain atrophy and tissue loss over five years in treatment-naive relapsing-remitting multiple sclerosis patients (46.36 -0.19) -Update-

http://biz.yahoo.com/bw/080417/20080417006156.html?.v=1

Co announces final results from a five-year comparative imaging study examining the long-term effect of disease-modifying therapies in treatment-naive, early relapsing-remitting multiple sclerosis patients, demonstrated that Copaxone treated patients experienced significantly less brain tissue loss, as measured by percent change in brain volume, compared with patients on other DMTs.